Clinical utility of (188)Rhenium-hydroxyethylidene-1,1-diphosphonate as a bone pain palliative in multiple malignancies

(188)Rhenium-hydroxyethylidene-1,1-diphosphonate ((188)Re-HEDP) is a clinically established radiopharmaceutical for bone pain palliation of patients with metastatic bone cancer. Herein, the effectiveness of (188)Re-HEDP for the palliation of painful bone metastases was investigated in an uncontrolle...

詳細記述

保存先:
書誌詳細
出版年:World J Nucl Med
主要な著者: Shinto, Ajit S., Mallia, Madhava B., Kameswaran, Mythili, Kamaleshwaran, K. K., Joseph, Jephy, Radhakrishnan, E. R., Upadhyay, Indira V., Subramaniam, R., Sairam, Madhu, Banerjee, Sharmila, Dash, Ashutosh
フォーマット: Artigo
言語:Inglês
出版事項: Medknow Publications & Media Pvt Ltd 2018
主題:
Original Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6216741/
https://ncbi.nlm.nih.gov/pubmed/30505219
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/wjnm.WJNM_68_17
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料